Ignite Creation Date:
2024-05-05 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00481455
Status:
COMPLETED
Last Update Posted:
2008-11-25
First Post:
2007-05-30
Brief Title:
Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion NCD in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme GBM
Sponsor:
CASI Pharmaceuticals Inc
Organization:
CASI Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-04
Start Date Type:
None
Primary Completion Date:
2007-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-10
Completion Date Type:
ACTUAL
First Submit Date:
2007-05-30
First Submit QC Date:
May 30 2007
Study First Post Date:
2007-06-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-11-24
Last Update Post Date:
2008-11-25
Last Update Post Date Type:
ESTIMATED